US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

I-MAB

3.72

+0.10002.76%

Pre-market: 3.58-0.1397-3.76%08:18 EDT

Volume:1.19M

Turnover:4.47M

Market Cap:427.78M

PE:-8.20

High:3.86

Open:3.62

Low:3.52

Close:3.62

52wk High:5.90

52wk Low:0.5950

Shares:114.99M

Float Shares:48.23M

Volume Ratio:0.50

T/O Rate:2.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4537

EPS(LYR):-0.2738

ROE:-17.08%

ROA:-10.36%

PB:2.17

PE(LYR):-13.59

Loading ...

Overview Company News Filings

I-Mab : Qtrly Net Loss per Ads $0.07

THOMSON REUTERS

Press Release: I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update

I-Mab Shares Rise After Completing Enrollment in Givastomig Trial

I-Mab - Topline Results Expected in Q1 2026

THOMSON REUTERS

I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers

I-Mab Files Prospectus Supplement for $65 Million Underwritten ADS Offering to Advance Cancer Treatment Pipeline

Top Midday Gainers

MT Newswires Live

I-Mab Prices $65 Million Offering of American Depositary Shares

MT Newswires Live

Everest Medicines Ltd. Expands Stake with $30.9 Million Investment in U.S.-Based Biotech Firm I-Mab

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares

BRIEF-I-Mab Strengthens Givastomig Intellectual Property Portfolio Through Acquisition Of Bridge Health

I-Mab to Acquire Bridge Health Biotech

MT Newswires Live

I-Mab Announces Phase 1b Dose Expansion Progress for Givastomig, Anticipates Topline Readout in Q1 2026

I-Mab to Present at the BTIG Virtual Biotechnology Conference

I-Mab Price Target Maintained With a $5.00/Share by Needham

I-Mab Unveils Corporate Presentation Highlighting Innovative Drug Development and Promising Cancer Therapies

I-Mab to Present Positive Phase 1b Givastomig Data at ESMO GI 2025

I-Mab Is Maintained at Buy by Needham

I-Mab Announces Promising Phase 1b Trial Results for Givastomig in Combination with Immunochemotherapy for Gastric Cancer at ESMO GI 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IMAB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMAB\",,,,,undefined,":{"symbol":"IMAB","market":"US","secType":"STK","nameCN":"I-MAB","latestPrice":3.72,"timestamp":1758052800000,"preClose":3.62,"halted":0,"volume":1194726,"hourTrading":{"tag":"盘前","latestPrice":3.5803,"preClose":3.72,"latestTime":"08:18 EDT","volume":38112,"amount":135303.9037248,"timestamp":1758111491978},"delay":0,"floatShares":48234000,"shares":114993676,"eps":-0.453699,"marketStatus":"Pre-Mkt","change":0.1,"latestTime":"09-17 09:01:23 EDT","open":3.62,"high":3.86,"low":3.52,"amount":4467649.6814664,"amplitude":0.093923,"askPrice":3.88,"askSize":700,"bidPrice":3.58,"bidSize":208,"shortable":3,"etf":0,"ttmEps":-0.453699,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1758115800000},"marketStatusCode":1,"adr":0,"adrRate":2.3,"listingDate":1579237200000,"exchange":"NASDAQ","adjPreClose":3.72,"preHourTrading":{"tag":"盘前","latestPrice":3.5803,"preClose":3.72,"latestTime":"08:18 EDT","volume":38112,"amount":135303.9037248,"timestamp":1758111491978},"postHourTrading":{"tag":"盘后","latestPrice":3.82,"preClose":3.72,"latestTime":"19:08 EDT","volume":3280,"amount":12103.3622,"timestamp":1758064097470},"volumeRatio":0.49706768047838407,"impliedVol":1.5632,"impliedVolPercentile":0.6426},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMAB\",,,,,undefined,":{"symbol":"IMAB","floatShares":48234000,"roa":"-10.36%","roe":"-17.08%","lyrEps":-0.273814,"volumeRatio":0.49706768047838407,"shares":114993676,"dividePrice":0,"high":3.86,"amplitude":0.093923,"preClose":3.62,"low":3.52,"week52Low":0.595,"pbRate":"2.17","psRate":"751.19","week52High":5.9,"institutionHeld":0,"latestPrice":3.72,"committee":-0.54185,"eps":-0.453699,"divideRate":0,"volume":1194726,"delay":0,"ttmEps":-0.453699,"open":3.62,"prevYearClose":0.85,"prevWeekClose":4.09,"prevMonthClose":4.16,"prevQuarterClose":2.42,"fiveDayClose":4.6,"twentyDayClose":5.09,"sixtyDayClose":2.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-20","symbol":"IMAB","fiscalQuarterEnding":"2025/06","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-05-15","symbol":"IMAB","fiscalQuarterEnding":"2025/03","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2025-04-03","symbol":"IMAB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743652800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"IMAB","fiscalQuarterEnding":"2024/09","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2024-08-28","symbol":"IMAB","fiscalQuarterEnding":"2024/06","expectedEps":-0.51,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1724817600000,"reportTimeType":"pre","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1757563200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMAB","date":"2025-09-15","current":-12.721589,"percent":0.282573,"low":-1689.865005,"twenty":-18.679452,"median":-1.049822,"eighty":-0.551033,"high":89.207962,"avg":-121.522533,"sd":370.051672,"marketCap":470838730},"quantilePoints":[{"date":"2020-09-18","current":-14.058712,"twenty":-8.429351,"median":-5.926166,"eighty":-4.341342,"marketCap":2445509231},{"date":"2020-09-25","current":-14.774309,"twenty":-8.460705,"median":-6.291114,"eighty":-4.349885,"marketCap":2549573453},{"date":"2020-10-02","current":-15.896333,"twenty":-8.569235,"median":-6.502289,"eighty":-4.358077,"marketCap":2756367742},{"date":"2020-10-09","current":-15.018806,"twenty":-8.713013,"median":-6.7565,"eighty":-4.372664,"marketCap":2641630266},{"date":"2020-10-16","current":-15.423477,"twenty":-8.748043,"median":-6.914872,"eighty":-4.4139,"marketCap":2711673492},{"date":"2020-10-23","current":-15.407103,"twenty":-9.263043,"median":-6.95731,"eighty":-4.416016,"marketCap":2713007649},{"date":"2020-10-30","current":-15.60375,"twenty":-12.37131,"median":-7.079868,"eighty":-4.422909,"marketCap":2746361566},{"date":"2020-11-06","current":-13.368261,"twenty":-13.1388,"median":-7.39725,"eighty":-4.432434,"marketCap":2380802631},{"date":"2020-11-13","current":-13.854693,"twenty":-13.1388,"median":-7.916799,"eighty":-4.434075,"marketCap":2469524051},{"date":"2020-11-20","current":-15.19435,"twenty":-13.824088,"median":-8.030896,"eighty":-4.441452,"marketCap":2725682138},{"date":"2020-11-27","current":-13.892438,"twenty":-13.887091,"median":-8.087405,"eighty":-4.46663,"marketCap":2486868088},{"date":"2020-12-04","current":-14.055647,"twenty":-14.025232,"median":-8.093982,"eighty":-4.468857,"marketCap":2534230651},{"date":"2020-12-11","current":-13.774615,"twenty":-14.053404,"median":-8.12941,"eighty":-4.479372,"marketCap":2477528991},{"date":"2020-12-18","current":-14.750858,"twenty":-14.072288,"median":-8.190326,"eighty":-4.514385,"marketCap":2656973068},{"date":"2020-12-24","current":-16.245455,"twenty":-14.275539,"median":-8.225764,"eighty":-4.514729,"marketCap":2929096958},{"date":"2020-12-31","current":-18.429611,"twenty":-14.590695,"median":-8.246872,"eighty":-4.514842,"marketCap":3323872962},{"date":"2021-01-08","current":-22.38663,"twenty":-14.760238,"median":-8.277156,"eighty":-4.516642,"marketCap":4072537455},{"date":"2021-01-15","current":-19.210995,"twenty":-15.011201,"median":-8.298163,"eighty":-4.518014,"marketCap":3490947806},{"date":"2021-01-22","current":-21.435993,"twenty":-15.058039,"median":-8.33652,"eighty":-4.518577,"marketCap":3894183296},{"date":"2021-01-29","current":-20.936486,"twenty":-15.163975,"median":-8.348522,"eighty":-4.521786,"marketCap":3834261938},{"date":"2021-02-05","current":-31.382456,"twenty":-15.278197,"median":-8.389941,"eighty":-4.525873,"marketCap":4460701042},{"date":"2021-02-12","current":-29.353264,"twenty":-15.348013,"median":-8.421905,"eighty":-4.526665,"marketCap":4178669621},{"date":"2021-02-19","current":-29.217338,"twenty":-15.400209,"median":-8.431856,"eighty":-4.528627,"marketCap":4159963455},{"date":"2021-02-26","current":-29.988843,"twenty":-15.524712,"median":-8.457536,"eighty":-4.540087,"marketCap":4258530559},{"date":"2021-03-05","current":-25.054306,"twenty":-15.625141,"median":-8.507384,"eighty":-4.565159,"marketCap":3545537860},{"date":"2021-03-12","current":-28.023023,"twenty":-15.908375,"median":-8.607214,"eighty":-4.570267,"marketCap":3957792972},{"date":"2021-03-19","current":-27.002407,"twenty":-16.385481,"median":-8.677587,"eighty":-4.573885,"marketCap":3813179923},{"date":"2021-03-26","current":-23.870161,"twenty":-16.552171,"median":-8.723357,"eighty":-4.579968,"marketCap":3354159396},{"date":"2021-04-01","current":49.872512,"twenty":-16.527506,"median":-8.699728,"eighty":-4.56403,"marketCap":3577194448},{"date":"2021-04-09","current":51.707425,"twenty":-16.50033,"median":-8.636499,"eighty":-4.525609,"marketCap":3716051755},{"date":"2021-04-16","current":56.785568,"twenty":-16.446287,"median":-8.52092,"eighty":-4.51486,"marketCap":4100967087},{"date":"2021-04-23","current":63.232827,"twenty":-16.420487,"median":-8.462818,"eighty":-4.468857,"marketCap":4583730054},{"date":"2021-04-30","current":60.839599,"twenty":-16.245455,"median":-8.435247,"eighty":-4.432091,"marketCap":4424685133},{"date":"2021-05-07","current":58.635794,"twenty":-16.164805,"median":-8.421905,"eighty":-4.362415,"marketCap":4292183516},{"date":"2021-05-14","current":64.224736,"twenty":-15.940724,"median":-8.389941,"eighty":-4.333308,"marketCap":4698376996},{"date":"2021-05-21","current":68.211309,"twenty":-15.911386,"median":-8.348522,"eighty":-4.224104,"marketCap":4992342332},{"date":"2021-05-28","current":82.491248,"twenty":-15.896333,"median":-8.33652,"eighty":-4.052641,"marketCap":6099862697},{"date":"2021-06-04","current":79.729586,"twenty":-15.709401,"median":-8.298163,"eighty":-3.977808,"marketCap":5871127251},{"date":"2021-06-11","current":73.425637,"twenty":-15.641414,"median":-8.277156,"eighty":-3.80914,"marketCap":5403874909},{"date":"2021-06-18","current":75.69043,"twenty":-15.629661,"median":-8.246872,"eighty":-3.753801,"marketCap":5523509567},{"date":"2021-06-25","current":82.257731,"twenty":-15.616411,"median":-8.22505,"eighty":-3.689592,"marketCap":6000247739},{"date":"2021-07-02","current":86.319885,"twenty":-15.6057,"median":-8.178914,"eighty":-3.608003,"marketCap":6280992570},{"date":"2021-07-09","current":85.401322,"twenty":-15.579165,"median":-8.119381,"eighty":-3.533685,"marketCap":6207152834},{"date":"2021-07-16","current":81.961989,"twenty":-15.541624,"median":-8.093243,"eighty":45.67324,"marketCap":5957174560},{"date":"2021-07-23","current":77.53424,"twenty":-15.519088,"median":-8.08309,"eighty":49.716435,"marketCap":5633356550},{"date":"2021-07-30","current":82.406784,"twenty":-15.459472,"median":-7.997128,"eighty":51.483544,"marketCap":6005631887},{"date":"2021-08-06","current":76.523892,"twenty":-15.413653,"median":-7.783598,"eighty":55.650829,"marketCap":5558747649},{"date":"2021-08-13","current":74.247826,"twenty":-15.405977,"median":-7.311196,"eighty":57.257788,"marketCap":5397992390},{"date":"2021-08-20","current":63.481309,"twenty":-15.390174,"median":-7.029096,"eighty":58.281234,"marketCap":4598061913},{"date":"2021-08-27","current":67.239873,"twenty":-15.372862,"median":-6.92978,"eighty":59.725358,"marketCap":4892651695},{"date":"2021-09-03","current":-1568.124071,"twenty":-15.413653,"median":-6.970933,"eighty":59.725358,"marketCap":5517451088},{"date":"2021-09-10","current":-1572.196836,"twenty":-15.548675,"median":-7.079868,"eighty":59.277309,"marketCap":5541309504},{"date":"2021-09-17","current":-1661.842949,"twenty":-15.632881,"median":-7.39725,"eighty":58.633144,"marketCap":5837615637},{"date":"2021-09-24","current":-1489.852614,"twenty":-15.928989,"median":-7.916799,"eighty":58.60755,"marketCap":5233458976},{"date":"2021-10-01","current":-1566.811512,"twenty":-16.435967,"median":-8.030896,"eighty":58.379196,"marketCap":5520529593},{"date":"2021-10-08","current":-1550.482882,"twenty":-17.123466,"median":-8.087724,"eighty":58.0206,"marketCap":5465116498},{"date":"2021-10-15","current":-1435.3715,"twenty":-18.931299,"median":-8.094722,"eighty":57.857702,"marketCap":5066450064},{"date":"2021-10-22","current":-1458.811123,"twenty":-19.479011,"median":-8.153947,"eighty":57.754467,"marketCap":5189590275},{"date":"2021-10-29","current":-1341.147796,"twenty":-20.402127,"median":-8.201307,"eighty":57.421106,"marketCap":4755521031},{"date":"2021-11-05","current":-1322.636697,"twenty":-20.95038,"median":-8.234668,"eighty":56.872917,"marketCap":4694720552},{"date":"2021-11-12","current":-1299.110524,"twenty":-22.184405,"median":-8.252242,"eighty":56.639184,"marketCap":4625454183},{"date":"2021-11-19","current":-1484.148205,"twenty":-24.05261,"median":-8.286245,"eighty":56.242498,"marketCap":5277327676},{"date":"2021-11-26","current":-1368.839287,"twenty":-24.672318,"median":-8.320115,"eighty":55.868166,"marketCap":4864038342},{"date":"2021-12-03","current":-1139.715924,"twenty":-26.003072,"median":-8.34759,"eighty":55.338663,"marketCap":4059778838},{"date":"2021-12-10","current":-1152.870542,"twenty":-26.962417,"median":-8.354558,"eighty":54.546808,"marketCap":4111343801},{"date":"2021-12-17","current":-1030.956952,"twenty":-27.984112,"median":-8.421327,"eighty":52.658803,"marketCap":3672656799},{"date":"2021-12-23","current":-1013.014942,"twenty":-28.231103,"median":-8.431213,"eighty":51.707425,"marketCap":3611856319},{"date":"2021-12-31","current":-1020.102071,"twenty":-29.055429,"median":-8.445446,"eighty":51.33429,"marketCap":3647259130},{"date":"2022-01-07","current":-879.299363,"twenty":-29.262906,"median":-8.476593,"eighty":51.036417,"marketCap":3131609496},{"date":"2022-01-14","current":-783.773022,"twenty":-29.54444,"median":-8.556193,"eighty":50.015224,"marketCap":2802159105},{"date":"2022-01-21","current":-642.866959,"twenty":-31.073337,"median":-8.639212,"eighty":49.901054,"marketCap":2303429133},{"date":"2022-01-28","current":-499.156391,"twenty":-508.984537,"median":-8.72187,"eighty":49.664409,"marketCap":1782320252},{"date":"2022-02-04","current":-506.990688,"twenty":-551.675353,"median":-8.726959,"eighty":48.741584,"marketCap":1810293888},{"date":"2022-02-11","current":-528.486001,"twenty":-550.675991,"median":-8.875954,"eighty":48.004339,"marketCap":1888620070},{"date":"2022-02-18","current":-594.801454,"twenty":-594.967187,"median":-9.234558,"eighty":47.462959,"marketCap":2135587316},{"date":"2022-02-25","current":-554.867558,"twenty":-577.033556,"median":-11.846736,"eighty":45.67324,"marketCap":1994919888},{"date":"2022-03-04","current":-470.289306,"twenty":-577.082818,"median":-12.36135,"eighty":17.356377,"marketCap":1690406876},{"date":"2022-03-11","current":-373.876829,"twenty":-567.699494,"median":-12.679773,"eighty":-2.412395,"marketCap":1339537553},{"date":"2022-03-18","current":-438.510365,"twenty":-564.016922,"median":-12.888345,"eighty":-3.508272,"marketCap":1565724383},{"date":"2022-03-25","current":-398.475113,"twenty":-561.40929,"median":-13.129528,"eighty":-3.533685,"marketCap":1421859968},{"date":"2022-04-01","current":-3.944384,"twenty":-560.147337,"median":-13.10004,"eighty":-3.555763,"marketCap":1445375084},{"date":"2022-04-08","current":-3.192553,"twenty":-558.146588,"median":-12.764078,"eighty":-3.555763,"marketCap":1169672469},{"date":"2022-04-14","current":-3.007313,"twenty":-556.046447,"median":-12.530977,"eighty":-3.380436,"marketCap":1099508630},{"date":"2022-04-22","current":-3.040661,"twenty":-552.437696,"median":-12.027584,"eighty":-3.175086,"marketCap":1090428604},{"date":"2022-04-29","current":-2.933943,"twenty":-548.594589,"median":-10.509625,"eighty":-3.01027,"marketCap":1035122990},{"date":"2022-05-06","current":-2.860483,"twenty":-542.803867,"median":-9.085584,"eighty":-3.01027,"marketCap":1000453799},{"date":"2022-05-13","current":-2.883861,"twenty":-532.132793,"median":-8.741104,"eighty":-2.899071,"marketCap":990548316},{"date":"2022-05-20","current":-2.544895,"twenty":-527.587866,"median":-8.722336,"eighty":-2.883751,"marketCap":886540742},{"date":"2022-05-27","current":-1.961488,"twenty":-525.524385,"median":-8.659755,"eighty":-2.787209,"marketCap":682652881},{"date":"2022-06-03","current":-2.011377,"twenty":-522.371753,"median":-8.607214,"eighty":-2.677317,"marketCap":704114761},{"date":"2022-06-10","current":-2.261167,"twenty":-514.042248,"median":-8.507384,"eighty":-2.545111,"marketCap":785834997},{"date":"2022-06-17","current":-2.622866,"twenty":-512.578651,"median":-8.457536,"eighty":-2.488362,"marketCap":910478993},{"date":"2022-06-24","current":-2.924816,"twenty":-506.990688,"median":-8.435247,"eighty":-2.501037,"marketCap":1019439308},{"date":"2022-07-01","current":-2.725906,"twenty":-506.836382,"median":-8.421905,"eighty":-2.518456,"marketCap":948450012},{"date":"2022-07-08","current":-2.725184,"twenty":-500.692389,"median":-8.421119,"eighty":-2.539607,"marketCap":949275469},{"date":"2022-07-15","current":-2.14112,"twenty":-490.898893,"median":-8.349438,"eighty":-2.47675,"marketCap":738783952},{"date":"2022-07-22","current":-2.39033,"twenty":-479.973921,"median":-8.336523,"eighty":-2.428531,"marketCap":825456930},{"date":"2022-07-29","current":-2.502432,"twenty":-471.783199,"median":-8.298163,"eighty":-2.439076,"marketCap":865078862},{"date":"2022-08-05","current":-2.065973,"twenty":-468.357635,"median":-8.277156,"eighty":-2.373139,"marketCap":712369330},{"date":"2022-08-12","current":-1.904996,"twenty":-465.584187,"median":-8.246872,"eighty":-2.210559,"marketCap":658714630},{"date":"2022-08-19","current":-1.450657,"twenty":-451.507389,"median":-8.22505,"eighty":-2.138539,"marketCap":496099614},{"date":"2022-08-26","current":-1.459756,"twenty":-445.894877,"median":-8.178914,"eighty":-2.078079,"marketCap":495274158},{"date":"2022-09-02","current":-1.472072,"twenty":-439.875444,"median":-8.109351,"eighty":-2.043447,"marketCap":491114150},{"date":"2022-09-09","current":-1.442596,"twenty":-438.170475,"median":-8.093243,"eighty":-1.98984,"marketCap":479480312},{"date":"2022-09-16","current":-1.282022,"twenty":-422.388012,"median":-8.08309,"eighty":-1.913653,"marketCap":422142112},{"date":"2022-09-23","current":-1.181062,"twenty":-410.776992,"median":-7.997128,"eighty":-1.79632,"marketCap":381423680},{"date":"2022-09-30","current":-1.029866,"twenty":-405.790874,"median":-7.783598,"eighty":-1.511726,"marketCap":333226352},{"date":"2022-10-07","current":-0.94003,"twenty":-400.292309,"median":-7.311196,"eighty":-1.458505,"marketCap":304141758},{"date":"2022-10-14","current":-0.968283,"twenty":-390.171618,"median":-7.029096,"eighty":-1.439885,"marketCap":309958676},{"date":"2022-10-21","current":-1.014141,"twenty":-380.548428,"median":-6.92978,"eighty":-1.399971,"marketCap":322423503},{"date":"2022-10-28","current":-1.010614,"twenty":-375.455461,"median":-6.840112,"eighty":-1.346284,"marketCap":320761526},{"date":"2022-11-04","current":-0.990557,"twenty":-373.320567,"median":-6.68288,"eighty":-1.247417,"marketCap":317437572},{"date":"2022-11-11","current":-1.085268,"twenty":-330.518051,"median":-6.450263,"eighty":-1.188376,"marketCap":351508097},{"date":"2022-11-18","current":-1.046069,"twenty":-289.31232,"median":-6.244976,"eighty":-1.135802,"marketCap":338212282},{"date":"2022-11-25","current":-0.931884,"twenty":-181.370052,"median":-5.804466,"eighty":-1.075799,"marketCap":299155827},{"date":"2022-12-02","current":-0.967996,"twenty":-31.977742,"median":-5.321934,"eighty":-1.032523,"marketCap":317437572},{"date":"2022-12-09","current":-1.027099,"twenty":-31.227896,"median":-5.213735,"eighty":-1.025257,"marketCap":339874259},{"date":"2022-12-16","current":-0.911043,"twenty":-30.593171,"median":-5.096653,"eighty":-1.016305,"marketCap":300817804},{"date":"2022-12-23","current":-0.877781,"twenty":-29.925644,"median":-4.891082,"eighty":-1.009434,"marketCap":289183966},{"date":"2022-12-30","current":-1.040767,"twenty":-29.773565,"median":-4.843323,"eighty":-0.98957,"marketCap":347353155},{"date":"2023-01-06","current":-1.374757,"twenty":-29.54444,"median":-4.780821,"eighty":-0.990557,"marketCap":462860544},{"date":"2023-01-13","current":-1.790054,"twenty":-29.353264,"median":-4.719239,"eighty":-1.009277,"marketCap":614100434},{"date":"2023-01-20","current":-1.655167,"twenty":-29.314698,"median":-4.656554,"eighty":-1.009591,"marketCap":561748165},{"date":"2023-01-27","current":-1.665182,"twenty":-29.274873,"median":-4.610131,"eighty":-1.010425,"marketCap":565072118},{"date":"2023-02-03","current":-1.452523,"twenty":-29.26379,"median":-4.59275,"eighty":-1.0116,"marketCap":494438103},{"date":"2023-02-10","current":-1.245858,"twenty":-29.226452,"median":-4.572641,"eighty":-1.013682,"marketCap":421311123},{"date":"2023-02-17","current":-1.160244,"twenty":-29.151287,"median":-4.549065,"eighty":-1.018468,"marketCap":388902575},{"date":"2023-02-24","current":-1.04964,"twenty":-29.113758,"median":-4.526764,"eighty":-1.020818,"marketCap":347353155},{"date":"2023-03-03","current":-1.111949,"twenty":-29.073156,"median":-4.519238,"eighty":-1.022704,"marketCap":370620830},{"date":"2023-03-10","current":-0.924698,"twenty":-28.986303,"median":-4.516345,"eighty":-1.013223,"marketCap":307465711},{"date":"2023-03-17","current":-0.902368,"twenty":-28.939665,"median":-4.514385,"eighty":-1.009512,"marketCap":301648792},{"date":"2023-03-24","current":-0.768542,"twenty":-28.891041,"median":-4.467744,"eighty":-0.990063,"marketCap":257606407},{"date":"2023-03-31","current":-0.818905,"twenty":-28.48221,"median":-4.433804,"eighty":-0.978435,"marketCap":287521989},{"date":"2023-04-06","current":-0.837555,"twenty":-28.212182,"median":-4.420614,"eighty":-0.968111,"marketCap":293789092},{"date":"2023-04-14","current":-0.87691,"twenty":-28.161869,"median":-4.388037,"eighty":-0.960958,"marketCap":307897607},{"date":"2023-04-21","current":-0.759116,"twenty":-28.086592,"median":-4.348108,"eighty":-0.94928,"marketCap":266401973},{"date":"2023-04-28","current":-0.721927,"twenty":-27.945201,"median":-4.325143,"eighty":-0.942106,"marketCap":251463545},{"date":"2023-05-05","current":-0.703923,"twenty":-27.650065,"median":-4.291313,"eighty":-0.935502,"marketCap":245654156},{"date":"2023-05-12","current":-0.729231,"twenty":-27.278424,"median":-4.209154,"eighty":-0.924135,"marketCap":253123370},{"date":"2023-05-19","current":-0.760712,"twenty":-27.074385,"median":-4.151754,"eighty":-0.91299,"marketCap":260592584},{"date":"2023-05-26","current":-0.727929,"twenty":-26.922426,"median":-4.088028,"eighty":-0.911245,"marketCap":248143894},{"date":"2023-06-02","current":-0.739902,"twenty":-26.797824,"median":-4.011639,"eighty":-0.909096,"marketCap":251463545},{"date":"2023-06-09","current":-0.778114,"twenty":-26.708172,"median":-3.972375,"eighty":-0.895539,"marketCap":263912235},{"date":"2023-06-16","current":-0.755945,"twenty":-26.361854,"median":-3.89382,"eighty":-0.877084,"marketCap":255613108},{"date":"2023-06-23","current":-0.763382,"twenty":-26.114589,"median":-3.813385,"eighty":-0.872191,"marketCap":256443021},{"date":"2023-06-30","current":-0.741119,"twenty":-25.668521,"median":-3.794151,"eighty":-0.858221,"marketCap":246484068},{"date":"2023-07-07","current":-0.669817,"twenty":-25.255385,"median":-3.761146,"eighty":-0.839155,"marketCap":222784105},{"date":"2023-07-14","current":-0.71002,"twenty":-24.971082,"median":-3.7293,"eighty":-0.819715,"marketCap":239472053},{"date":"2023-07-21","current":-0.724967,"twenty":-24.798613,"median":-3.70037,"eighty":-0.809989,"marketCap":243644040},{"date":"2023-07-28","current":-0.692427,"twenty":-24.575709,"median":-3.645189,"eighty":-0.799078,"marketCap":232796874},{"date":"2023-08-04","current":-0.684255,"twenty":-24.392006,"median":-3.617548,"eighty":-0.794727,"marketCap":230293682},{"date":"2023-08-11","current":-0.636728,"twenty":-24.238122,"median":-3.581124,"eighty":-0.784869,"marketCap":212771337},{"date":"2023-08-18","current":-0.654537,"twenty":-23.991793,"median":-3.52969,"eighty":-0.778831,"marketCap":191911402},{"date":"2023-08-25","current":-0.533935,"twenty":-23.513416,"median":-3.296654,"eighty":-0.775789,"marketCap":156853498},{"date":"2023-09-01","current":-0.535372,"twenty":-22.963954,"median":-3.227716,"eighty":-0.770058,"marketCap":157683411},{"date":"2023-09-08","current":-0.480808,"twenty":-22.608372,"median":-3.210001,"eighty":-0.76178,"marketCap":140255244},{"date":"2023-09-15","current":-0.394093,"twenty":-22.184405,"median":-3.163442,"eighty":-0.759676,"marketCap":115772820},{"date":"2023-09-22","current":-0.334749,"twenty":-21.703038,"median":-3.044748,"eighty":-0.757264,"marketCap":97929697},{"date":"2023-09-29","current":-0.359971,"twenty":-21.321592,"median":-3.014705,"eighty":-0.755913,"marketCap":105398911},{"date":"2023-10-06","current":-0.393977,"twenty":-21.073852,"median":-2.937765,"eighty":-0.74201,"marketCap":115357863},{"date":"2023-10-13","current":-0.379785,"twenty":-20.95038,"median":-2.924816,"eighty":-0.73674,"marketCap":111208300},{"date":"2023-10-20","current":-0.370593,"twenty":-20.929694,"median":-2.896534,"eighty":-0.72845,"marketCap":108303606},{"date":"2023-10-27","current":-0.363567,"twenty":-20.922901,"median":-2.888979,"eighty":-0.724359,"marketCap":106228824},{"date":"2023-11-03","current":-0.474311,"twenty":-20.644443,"median":-2.87993,"eighty":-0.717474,"marketCap":138595419},{"date":"2023-11-10","current":-0.415638,"twenty":-20.555419,"median":-2.829541,"eighty":-0.710017,"marketCap":121997165},{"date":"2023-11-17","current":-0.455431,"twenty":-20.2539,"median":-2.808729,"eighty":-0.703666,"marketCap":134445855},{"date":"2023-11-24","current":-0.443843,"twenty":-20.112086,"median":-2.768073,"eighty":-0.698247,"marketCap":132786030},{"date":"2023-12-01","current":-0.43217,"twenty":-19.865735,"median":-2.733469,"eighty":-0.691065,"marketCap":129466379},{"date":"2023-12-08","current":-0.43274,"twenty":-19.592862,"median":-2.725184,"eighty":-0.68128,"marketCap":129466379},{"date":"2023-12-15","current":-0.419035,"twenty":-19.468329,"median":-2.688936,"eighty":-0.669561,"marketCap":126146728},{"date":"2023-12-20","current":-0.43214,"twenty":-19.446963,"median":-2.676115,"eighty":-0.654537,"marketCap":129466379},{"date":"2023-12-29","current":-0.504775,"twenty":-19.351772,"median":-2.622866,"eighty":-0.641152,"marketCap":151874022},{"date":"2024-01-05","current":-0.588114,"twenty":-19.272849,"median":-2.591343,"eighty":-0.638379,"marketCap":175941490},{"date":"2024-01-12","current":-0.573962,"twenty":-19.194144,"median":-2.56042,"eighty":-0.623581,"marketCap":171791926},{"date":"2024-01-19","current":-0.451174,"twenty":-19.12674,"median":-2.545976,"eighty":-0.603319,"marketCap":134030899},{"date":"2024-01-26","current":-0.501777,"twenty":-18.638138,"median":-2.535211,"eighty":-0.573962,"marketCap":150214196},{"date":"2024-02-02","current":-0.507324,"twenty":-18.429611,"median":-2.502432,"eighty":-0.552276,"marketCap":151044109},{"date":"2024-02-09","current":-0.497319,"twenty":-18.093577,"median":-2.495175,"eighty":-0.550244,"marketCap":148554371},{"date":"2024-02-16","current":-0.492473,"twenty":-17.500219,"median":-2.442979,"eighty":-0.533935,"marketCap":146894546},{"date":"2024-02-23","current":-0.438426,"twenty":-16.746713,"median":-2.432996,"eighty":-0.517701,"marketCap":130296292},{"date":"2024-03-01","current":-0.496823,"twenty":-16.533672,"median":-2.386795,"eighty":-0.511021,"marketCap":147724458},{"date":"2024-03-08","current":-0.480265,"twenty":-16.505765,"median":-2.327273,"eighty":-0.504949,"marketCap":142744982},{"date":"2024-03-15","current":-0.502689,"twenty":-16.457096,"median":-2.196039,"eighty":-0.504725,"marketCap":149384284},{"date":"2024-03-22","current":-0.717465,"twenty":-16.425647,"median":-2.162147,"eighty":-0.504949,"marketCap":146069881},{"date":"2024-03-28","current":-0.744114,"twenty":-16.315468,"median":-2.128215,"eighty":-0.505983,"marketCap":150911977},{"date":"2024-04-05","current":-0.716964,"twenty":-16.197065,"median":-2.088838,"eighty":-0.507052,"marketCap":145262865},{"date":"2024-04-12","current":-0.721262,"twenty":-16.030356,"median":-2.065973,"eighty":-0.507917,"marketCap":146069881},{"date":"2024-04-19","current":-0.717391,"twenty":-15.923121,"median":-2.042356,"eighty":-0.509792,"marketCap":145262865},{"date":"2024-04-26","current":-0.72201,"twenty":-15.902354,"median":-2.001916,"eighty":-0.51133,"marketCap":146069881},{"date":"2024-05-03","current":-0.703474,"twenty":-15.756134,"median":-1.943624,"eighty":-0.512995,"marketCap":142438309},{"date":"2024-05-10","current":-0.719588,"twenty":-15.646728,"median":-1.911131,"eighty":-0.515095,"marketCap":146069881},{"date":"2024-05-17","current":-0.703581,"twenty":-15.631271,"median":-1.902862,"eighty":-0.516186,"marketCap":142841817},{"date":"2024-05-24","current":-0.69781,"twenty":-15.619321,"median":-1.674681,"eighty":-0.516435,"marketCap":141227786},{"date":"2024-05-31","current":-0.69381,"twenty":-15.609601,"median":-1.655167,"eighty":-0.516663,"marketCap":140420770},{"date":"2024-06-07","current":-0.745957,"twenty":-15.58736,"median":-1.641485,"eighty":-0.517362,"marketCap":150911977},{"date":"2024-06-14","current":-0.742651,"twenty":-15.555725,"median":-1.601336,"eighty":-0.51975,"marketCap":150104961},{"date":"2024-06-21","current":-0.675623,"twenty":-15.527524,"median":-1.561161,"eighty":-0.526727,"marketCap":136385690},{"date":"2024-06-28","current":-0.676358,"twenty":-15.5219,"median":-1.553725,"eighty":-0.528901,"marketCap":136385690},{"date":"2024-07-05","current":-0.600454,"twenty":-15.495467,"median":-1.532879,"eighty":-0.532517,"marketCap":121052388},{"date":"2024-07-12","current":-0.63141,"twenty":-15.420202,"median":-1.513155,"eighty":-0.534017,"marketCap":127508515},{"date":"2024-07-15","current":-0.68704,"twenty":-15.416927,"median":-1.502692,"eighty":-0.534099,"marketCap":138806738},{"date":"2024-08-02","current":-0.522394,"twenty":-15.413653,"median":-1.492228,"eighty":-0.533226,"marketCap":105719085},{"date":"2024-08-09","current":-0.414779,"twenty":-15.405977,"median":-1.479623,"eighty":-0.517576,"marketCap":84736671},{"date":"2024-08-16","current":-0.434525,"twenty":-15.390174,"median":-1.459756,"eighty":-0.515095,"marketCap":88771751},{"date":"2024-08-23","current":-0.472071,"twenty":-15.372862,"median":-1.45159,"eighty":-0.507917,"marketCap":96841910},{"date":"2024-08-30","current":-0.808589,"twenty":-15.363333,"median":-1.442596,"eighty":-0.507917,"marketCap":90385783},{"date":"2024-09-06","current":-0.764938,"twenty":-15.348013,"median":-1.431576,"eighty":-0.508957,"marketCap":85506414},{"date":"2024-09-13","current":-0.757653,"twenty":-15.322182,"median":-1.405763,"eighty":-0.510264,"marketCap":84692067},{"date":"2024-09-20","current":-0.808649,"twenty":-15.303379,"median":-1.39417,"eighty":-0.511146,"marketCap":90392494},{"date":"2024-09-27","current":-0.808649,"twenty":-15.289817,"median":-1.374567,"eighty":-0.512563,"marketCap":90392494},{"date":"2024-10-04","current":-0.947066,"twenty":-15.278197,"median":-1.352472,"eighty":-0.514684,"marketCap":105865084},{"date":"2024-10-11","current":-0.954351,"twenty":-15.254938,"median":-1.323481,"eighty":-0.516097,"marketCap":106679430},{"date":"2024-10-18","current":-1.16562,"twenty":-15.220809,"median":-1.282022,"eighty":-0.516412,"marketCap":130295488},{"date":"2024-10-25","current":-0.89607,"twenty":-15.185046,"median":-1.265704,"eighty":-0.516663,"marketCap":100164656},{"date":"2024-10-31","current":-0.808649,"twenty":-15.167532,"median":-1.261832,"eighty":-0.517147,"marketCap":90392494},{"date":"2024-11-08","current":-0.786793,"twenty":-15.152368,"median":-1.235922,"eighty":-0.518884,"marketCap":87949454},{"date":"2024-11-15","current":-0.779508,"twenty":-15.145887,"median":-1.215014,"eighty":-0.523261,"marketCap":87135107},{"date":"2024-11-22","current":-0.949791,"twenty":-15.120699,"median":-1.194313,"eighty":-0.527814,"marketCap":78159541},{"date":"2024-11-29","current":-0.923249,"twenty":-15.063857,"median":-1.192572,"eighty":-0.532163,"marketCap":75975312},{"date":"2024-12-06","current":-1.039918,"twenty":-15.049312,"median":-1.169255,"eighty":-0.533935,"marketCap":85576140},{"date":"2024-12-13","current":-0.990398,"twenty":-15.022257,"median":-1.158354,"eighty":-0.534346,"marketCap":81501086},{"date":"2024-12-20","current":-0.944047,"twenty":-15.018806,"median":-1.124754,"eighty":-0.535372,"marketCap":77686835},{"date":"2024-12-27","current":-0.891358,"twenty":-15.008666,"median":-1.112244,"eighty":-0.538646,"marketCap":73350977},{"date":"2025-01-03","current":-0.8973,"twenty":-14.948936,"median":-1.098583,"eighty":-0.545932,"marketCap":73839983},{"date":"2025-01-10","current":-1.089438,"twenty":-14.874512,"median":-1.092288,"eighty":-0.55077,"marketCap":89651194},{"date":"2025-01-17","current":-1.089438,"twenty":-14.820071,"median":-1.085268,"eighty":-0.551559,"marketCap":89651194},{"date":"2025-01-24","current":-1.049822,"twenty":-14.820071,"median":-1.079534,"eighty":-0.551559,"marketCap":86391151},{"date":"2025-01-31","current":-1.049822,"twenty":-14.820071,"median":-1.06963,"eighty":-0.551559,"marketCap":86391151},{"date":"2025-02-07","current":-0.95514,"twenty":-14.820071,"median":-1.063628,"eighty":-0.551559,"marketCap":78599647},{"date":"2025-02-14","current":-0.940878,"twenty":-14.820071,"median":-1.057971,"eighty":-0.551559,"marketCap":77426031},{"date":"2025-02-21","current":-1.258389,"twenty":-14.820071,"median":-1.057971,"eighty":-0.551559,"marketCap":78722905},{"date":"2025-02-28","current":-1.171564,"twenty":-14.820071,"median":-1.057971,"eighty":-0.551559,"marketCap":73291212},{"date":"2025-03-07","current":-1.127955,"twenty":-14.838218,"median":-1.054169,"eighty":-0.551296,"marketCap":70563150},{"date":"2025-03-14","current":-1.092939,"twenty":-14.838218,"median":-1.050095,"eighty":-0.551296,"marketCap":68372557},{"date":"2025-03-21","current":-1.120666,"twenty":-14.838218,"median":-1.050095,"eighty":-0.551296,"marketCap":70107116},{"date":"2025-03-28","current":-1.095152,"twenty":-14.838218,"median":-1.050095,"eighty":-0.551296,"marketCap":68510996},{"date":"2025-04-04","current":-0.950398,"twenty":-14.838218,"median":-1.049822,"eighty":-0.551296,"marketCap":59455459},{"date":"2025-04-11","current":-2.471796,"twenty":-14.820071,"median":-1.049822,"eighty":-0.551559,"marketCap":54948030},{"date":"2025-04-17","current":-3.084539,"twenty":-14.820071,"median":-1.049822,"eighty":-0.551559,"marketCap":68569307},{"date":"2025-04-25","current":-3.124758,"twenty":-14.838218,"median":-1.049822,"eighty":-0.551296,"marketCap":69463373},{"date":"2025-05-02","current":-3.198817,"twenty":-14.838218,"median":-1.049822,"eighty":-0.551296,"marketCap":71109695},{"date":"2025-05-09","current":-3.226314,"twenty":-14.838218,"median":-1.049822,"eighty":-0.551296,"marketCap":71720953},{"date":"2025-05-16","current":-3.244645,"twenty":-14.838218,"median":-1.049822,"eighty":-0.551296,"marketCap":72128459},{"date":"2025-05-23","current":-9.460815,"twenty":-14.838218,"median":-1.049822,"eighty":-0.551296,"marketCap":85743363},{"date":"2025-05-30","current":-11.352977,"twenty":-14.838218,"median":-1.049822,"eighty":-0.551296,"marketCap":102892035},{"date":"2025-06-06","current":-20.633586,"twenty":-15.019496,"median":-1.049822,"eighty":-0.551296,"marketCap":187002192},{"date":"2025-06-13","current":-23.246573,"twenty":-15.149565,"median":-1.049822,"eighty":-0.551296,"marketCap":210683692},{"date":"2025-06-20","current":-20.993998,"twenty":-15.249441,"median":-1.049822,"eighty":-0.551033,"marketCap":190268606},{"date":"2025-06-27","current":-18.200805,"twenty":-15.341911,"median":-1.049822,"eighty":-0.551033,"marketCap":164953898},{"date":"2025-07-03","current":-19.372144,"twenty":-15.405977,"median":-1.049822,"eighty":-0.551033,"marketCap":175569743},{"date":"2025-07-11","current":-18.471114,"twenty":-15.579165,"median":-1.049822,"eighty":-0.551033,"marketCap":167403709},{"date":"2025-07-18","current":-19.462247,"twenty":-15.756134,"median":-1.049822,"eighty":-0.551033,"marketCap":176386347},{"date":"2025-07-25","current":-19.101835,"twenty":-16.197065,"median":-1.049822,"eighty":-0.551033,"marketCap":173119933},{"date":"2025-08-01","current":-18.110702,"twenty":-16.5112,"median":-1.049822,"eighty":-0.551033,"marketCap":164137295},{"date":"2025-08-08","current":-31.626152,"twenty":-17.737562,"median":-1.049822,"eighty":-0.551033,"marketCap":286627814},{"date":"2025-08-15","current":-65.471408,"twenty":-18.446212,"median":-1.049822,"eighty":-0.551033,"marketCap":593367368},{"date":"2025-08-22","current":-14.634033,"twenty":-18.679452,"median":-1.049822,"eighty":-0.551033,"marketCap":541620213},{"date":"2025-08-29","current":-13.204807,"twenty":-18.679452,"median":-1.049822,"eighty":-0.551033,"marketCap":488723123},{"date":"2025-09-05","current":-13.515509,"twenty":-18.700109,"median":-1.049731,"eighty":-0.55077,"marketCap":500222490},{"date":"2025-09-12","current":-12.117353,"twenty":-18.679452,"median":-1.049822,"eighty":-0.551033,"marketCap":448475336},{"date":"2025-09-15","current":-12.721589,"twenty":-18.679452,"median":-1.049822,"eighty":-0.551033,"marketCap":470838730}],"updateTime":1758077266717},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMAB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560774011","title":"I-Mab : Qtrly Net Loss per Ads $0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2560774011","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560774011?lang=en_us&edition=fundamental","pubTime":"2025-08-20 19:00","pubTimestamp":1755687601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nTUA2F1CJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4139","IMAB","BK4505","BK4526"],"gpt_icon":0},{"id":"2560177821","title":"Press Release: I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2560177821","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560177821?lang=en_us&edition=fundamental","pubTime":"2025-08-20 19:00","pubTimestamp":1755687600,"startTime":"0","endTime":"0","summary":"-- Positive givastomig Phase 1b dose escalation data in combination with. immunochemotherapy in patients with 1L gastric cancers presented at ESMO. GI 2025 showing 83% ORR at doses selected for ongoing expansion study. -- Topline data from planned dose expansion study of givastomig expected in. \"The first half of 2025 has been transformative for I-Mab,\" said Sean Fu, PhD, Chief Executive Officer of I-Mab. \"Our presentation at ESMO GI showcased compelling Phase 1b combination data for givastomig, reinforcing our confidence in its potential to be a best-in-class Claudin 18.2-directed therapy for metastatic gastric cancers in the 1L setting. Thanks to strong study momentum and active investigator engagement, we completed enrollment of the planned Phase 1b dose expansion cohorts ahead of schedule and expect to report topline data in Q1 2026. We believe our strong cash position and unwavering focus on value creation, position I-Mab to deliver meaningful clinical data and improve the lives o","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","CCR","BK4535","IMAB","BK4526","BK4139","ORR"],"gpt_icon":0},{"id":"2558647276","title":"I-Mab Shares Rise After Completing Enrollment in Givastomig Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2558647276","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558647276?lang=en_us&edition=fundamental","pubTime":"2025-08-12 00:35","pubTimestamp":1754930100,"startTime":"0","endTime":"0","summary":"I-Mab shares were 13% higher, at $3.84, after the company said enrollment in its planned Phase 1b dose expansion cohorts evaluating givastomig in combination with nivolumab and mFOLFOX6 has been completed ahead of expectations.The biotechnology company said the Phase 1b study is evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of givastomig, a potential best-in-class, bispecific antibody, used with nivolumab and mFOLFOX6, as first line therapy in patients with positive gastric cancers.The primary endpoint is safety. The dose expansion cohorts of the study enrolled a total of 40 patients across two doses--8 mg/kg and 12 mg/kg-- and enrolled only patients in the U.S.The stock hit its 52-week high of $4.18 on Thursday, and is up 260% in the past 12 months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","IMAB","BK4526","BK4535","BK4139"],"gpt_icon":0},{"id":"2558743651","title":"I-Mab - Topline Results Expected in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2558743651","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558743651?lang=en_us&edition=fundamental","pubTime":"2025-08-11 19:00","pubTimestamp":1754910001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nTUA966SGD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4505","BK4139","IMAB","BK4526"],"gpt_icon":0},{"id":"2558265251","title":"I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2558265251","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558265251?lang=en_us&edition=fundamental","pubTime":"2025-08-11 19:00","pubTimestamp":1754910000,"startTime":"0","endTime":"0","summary":"Enrollment in the planned second dose expansion cohort completed ahead of expectationsTopline results expected in Q1 2026 Positive Phase 1b dose escalation data presented at ESMO GI on July 2nd ROCKVI","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/11/3130776/0/en/I-Mab-Completes-Enrollment-in-Planned-Phase-1b-Dose-Expansion-Study-for-Givastomig-in-Combination-with-Immunochemotherapy-in-Patients-with-1L-Gastric-Cancers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4181","LU1169589451.USD","PK","IMAB","BK4505","BK4023","BK4139","ORR","BK4526","PD","LU1169590202.USD","BK4218"],"gpt_icon":0},{"id":"2556038587","title":"I-Mab Files Prospectus Supplement for $65 Million Underwritten ADS Offering to Advance Cancer Treatment Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2556038587","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556038587?lang=en_us&edition=fundamental","pubTime":"2025-08-04 19:01","pubTimestamp":1754305273,"startTime":"0","endTime":"0","summary":"I-Mab, a global biotech company listed on NASDAQ under the ticker IMAB, has announced the pricing of a $65 million underwritten offering of American Depositary Shares . The offering consists of 33,333,334 ADSs, representing 76,666,668 ordinary shares, each priced at $1.95. The company plans to use the proceeds to fund clinical development of its pipeline products, including a Phase 2 trial of givastomig, and for general corporate purposes. The offering, set to close on August 5, 2025, is led by Leerink Partners with BTIG and Lucid Capital Markets also participating. A prospectus supplement has been filed with the SEC and is available for public access.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. I-Mab published the original content ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL5wMl1p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","IMAB","BK4139","BK4526","BK4505"],"gpt_icon":0},{"id":"2556848563","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2556848563","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556848563?lang=en_us&edition=fundamental","pubTime":"2025-08-02 01:29","pubTimestamp":1754069361,"startTime":"0","endTime":"0","summary":"Performant Healthcare  agreed to be acquired by Machinify, a health-care intelligence company backed by New Mountain Capital, for $670 million.Shares of Performant more than doubled as intraday volume topped 14.4 million shares versus the daily average of almost 192,000.Tenon Medical  acquired sacroiliac joint-focused assets from Tampa, Florida-based startup SiVantage.Shares of Tenon rose 54% as volume topped 220.7 million versus the daily average of almost 212,000.I-MAB  priced an underwritten offering of 33.3 million American depositary shares, representing 76.7 million ordinary shares, at $1.95 each for total proceeds of $65 million.The stock jumped 25% as volume topped 41 million versus the daily average of about 587,000.Price: 7.62, Change: +4.07, Percent Change: +114.65","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TNON","BK4535","BK4082","BK4505","BK4526","PHLT","BK4196","IMAB"],"gpt_icon":0},{"id":"2556141388","title":"I-Mab Prices $65 Million Offering of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2556141388","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556141388?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:28","pubTimestamp":1754054935,"startTime":"0","endTime":"0","summary":"I-MAB  said Friday that it has priced an underwritten offering of 33.3 million American depositary shares, representing 76.7 million ordinary shares, at $1.95 each for total proceeds of $65 million.I-Mab said that it expects to close the offering around Tuesday, with the proceeds going toward clinical development of drug candidates and general corporate purposes.Shares of I-Mab were up more than 18% in recent Friday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4107","BK4505","IMAB","BK4526","AFG","BK4117","BK4535","BK4139"],"gpt_icon":0},{"id":"2556668815","title":"Everest Medicines Ltd. Expands Stake with $30.9 Million Investment in U.S.-Based Biotech Firm I-Mab","url":"https://stock-news.laohu8.com/highlight/detail?id=2556668815","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556668815?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:17","pubTimestamp":1754050665,"startTime":"0","endTime":"0","summary":"Everest Medicines Ltd., a biopharmaceutical company, has expanded its portfolio by subscribing to 15,846,154 American depositary shares of I-Mab, a U.S.-based biotech company specializing in precision immuno-oncology agents. The transaction, valued at approximately US$30.9 million, enhances Everest Medicines' stake in I-Mab to 16.1% of its total issued share capital. This strategic move aligns with Everest Medicines' commitment to advancing novel therapies addressing critical unmet medical needs. The company continues to build its portfolio of first-in-class or best-in-class products, further solidifying its presence in the global biotech industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the orig","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL9T24Wl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4526","BK1161","IMAB","BK1574","BK1583","BK4505","BK4535","01952"],"gpt_icon":0},{"id":"2556815377","title":"I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2556815377","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556815377?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:00","pubTimestamp":1754049600,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Aug.  01, 2025  (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the tre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/01/3125737/0/en/I-Mab-Announces-Pricing-of-65-Million-Underwritten-Offering-of-American-Depositary-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","BK4117","BK4139","PFS","BK4505","BK4535","BK4107","BK4211","BK4526","IMAB","BK4195"],"gpt_icon":0},{"id":"2552486738","title":"BRIEF-I-Mab Strengthens Givastomig Intellectual Property Portfolio Through Acquisition Of Bridge Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486738","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486738?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:57","pubTimestamp":1752753448,"startTime":"0","endTime":"0","summary":"BRIEF-I-Mab Strengthens Givastomig Intellectual Property Portfolio Through Acquisition Of Bridge HealthI-Mab IMAB.O:I-MAB STRENGTHENS GIVASTOMIG INTELLECTUAL PROPERTY PORTFOLIO THROUGH ACQUISITION OF ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUA4SYNFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4526","BK4535","BK4505","IMAB"],"gpt_icon":0},{"id":"2552486379","title":"I-Mab to Acquire Bridge Health Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486379","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486379?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:30","pubTimestamp":1752751835,"startTime":"0","endTime":"0","summary":"I-Mab  said Thursday it has agreed to buy Bridge Health Biotech for an upfront payment of $1.8 million, plus $1.2 million in non-contingent payments through 2027.Bridge Health Biotech shareholders may also be entitled to future milestone payments of up to about $3.9 million, I-Mab said.The deal, which will likely be completed in Q3, gives I-Mab upstream rights to the CLDN18.2 parental antibody for use in bispecific and multi-specific applications, the company added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMAB","BK4505","BK4139","BK4526","BK4535"],"gpt_icon":0},{"id":"2552160485","title":"I-Mab Announces Phase 1b Dose Expansion Progress for Givastomig, Anticipates Topline Readout in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2552160485","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552160485?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:05","pubTimestamp":1752750346,"startTime":"0","endTime":"0","summary":"I-Mab, a U.S.-based global biotech company, has announced significant progress in the clinical development of its investigational therapy, givastomig. The company recently presented positive Phase 1b dose escalation data at ESMO GI 2025, which has strengthened their confidence in givastomig's potential as a best-in-class CLDN18.2-directed therapy for the treatment of gastric cancers and other applications. Following this progress, I-Mab reports faster than anticipated enrollment in the Phase 1b dose expansion cohorts. The company anticipates providing a topline readout of the study in the first quarter of 2026. This development follows I-Mab's strategic acquisition of Bridge Health, which enhances the intellectual property portfolio of givastomig by securing upstream rights and eliminating royalty obligations related to the CLDN18.2 parental antibody.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDLrFVPl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4526","IMAB","BK4505","BK4535"],"gpt_icon":0},{"id":"2551188537","title":"I-Mab to Present at the BTIG Virtual Biotechnology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2551188537","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551188537?lang=en_us&edition=fundamental","pubTime":"2025-07-14 19:00","pubTimestamp":1752490800,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., July  14, 2025  (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/14/3114624/0/en/I-Mab-to-Present-at-the-BTIG-Virtual-Biotechnology-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMAB","BK4535","BK4505","BK4139","BK4526"],"gpt_icon":0},{"id":"2550639615","title":"I-Mab Price Target Maintained With a $5.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2550639615","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550639615?lang=en_us&edition=fundamental","pubTime":"2025-07-09 18:45","pubTimestamp":1752057900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMAB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 09, 2025 06:45 ET (10:45 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMAB"],"gpt_icon":0},{"id":"2548354811","title":"I-Mab Unveils Corporate Presentation Highlighting Innovative Drug Development and Promising Cancer Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2548354811","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548354811?lang=en_us&edition=fundamental","pubTime":"2025-07-03 00:34","pubTimestamp":1751474089,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. I-Mab published the original content used to generate this news brief on July 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL32B6sV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","IMAB","BK4505","BK4139","BK4526"],"gpt_icon":0},{"id":"2548581505","title":"I-Mab to Present Positive Phase 1b Givastomig Data at ESMO GI 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2548581505","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548581505?lang=en_us&edition=fundamental","pubTime":"2025-07-02 23:19","pubTimestamp":1751469577,"startTime":"0","endTime":"0","summary":"I-Mab, a U.S.-based biotech company, is set to present positive Phase 1b combination data for givastomig in combination with nivolumab and mFOLFOX6 at the European Society for Medical Oncology Gastrointestinal Cancers Congress 2025  in Barcelona. The company will host a virtual investor event to review these data on Tuesday, July 8th.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. I-Mab published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL9pnjqn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","IMAB","BK4505","BK4139","BK4526"],"gpt_icon":0},{"id":"2546711376","title":"I-Mab Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2546711376","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546711376?lang=en_us&edition=fundamental","pubTime":"2025-06-27 17:47","pubTimestamp":1751017620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMAB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 27, 2025 05:47 ET (09:47 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMAB"],"gpt_icon":0},{"id":"2546781656","title":"I-Mab Announces Promising Phase 1b Trial Results for Givastomig in Combination with Immunochemotherapy for Gastric Cancer at ESMO GI 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2546781656","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546781656?lang=en_us&edition=fundamental","pubTime":"2025-06-26 18:30","pubTimestamp":1750933853,"startTime":"0","endTime":"0","summary":"I-Mab Announces Promising Phase 1b Trial Results for Givastomig in Combination with Immunochemotherapy for Gastric Cancer at ESMO GI 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. I-Mab published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL23FjCs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4526","BK4535","IMAB","BK4505"],"gpt_icon":0},{"id":"2542336053","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2542336053","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542336053?lang=en_us&edition=fundamental","pubTime":"2025-06-09 22:38","pubTimestamp":1749479935,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were higher on Monday morning, up 0.9% to 2,313.18 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by biotech firm I-Mab  and cosmetics and skincare company Yatsen , which advanced 18% and 8%, respectively.They were followed by technology companies Xunlei  and Tuya , which climbed 9% and 6.5%, respectively.The decliners from North Asia were led by pet-focused online platform Boqii  and tea drinks brand Chagee , which fell 6.9% and 3%, respectively.From South Asia, the gainers were led by technology company Wipro , which rose 1%.The decliners from South Asia were led by HDFC Bank , which fell 1.7%, followed by ICICI Bank , which was down 1.4%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0528227936.USD","BK4509","SG9999004220.SGD","WIT","BK4207","SG9999014005.SGD","LU0197229882.USD","LU1791710400.SGD","AFG","LU0918141887.USD","YSG","IBN","BK4107","LU0072462343.USD","LU0348766576.USD","LU0541502299.USD","LU2226246903.HKD","BQ","LU0287143357.SGD","LU0048575426.USD","IE00B7N09G41.SGD","LU0390134368.USD","XNET","LU0143863784.USD","BK4134","LU0264410563.USD","BK4200","LU0868486357.SGD","BK4505","BK4535","LU0066902890.USD","LU0197773160.USD","TUYA","IE00B0JY6M65.USD","LU0821914370.USD","LU1868837565.USD","HDB","LU0231203729.USD","LU0541501648.USD","LU1282648689.USD","IMAB","IE00BYTNYM70.SGD","LU0823038988.USD","LU0164881194.USD","LU0708995666.HKD","LU1805238398.USD","LU0251143458.SGD","BK4117","LU0348744763.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}